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ABSTRACT: Cancer is one of the leading causes of death worldwide. Deaths from cancer 
are continuously rising worldwide with a projection of about 12 million deaths from cancer 
in 2030. Hence, over the past few years, tremendous attention has been given to the cancer 
related research and there has been an outstanding progress in the basic cancer biology. 
The present article deals with the recent developments in cancer nanotechnologies and its 
potential application in cancer therapeutics. Nanotechnology is one of the most rapidly 
growing fields in the 21
st century. It may be defined as the creation of materials, drugs and 
devices that are used to manipulate matter of size in the range of 1-100nm. 
Nanotechnology has found its applications in many fields related to medicine including 
novel drug delivery systems, biotechnology to name a few. Many different types of 
nanosystems have been utilized in diagnostics and therapeutics of various diseases. To 
subside the disadvantages of conventional cancer therapeutics, nanotechnology has been 
given considerable attention. In this paper, the current nanotechnologies that can be 
utilized in oncological interventions will be discussed. These  mainly include arrays of 
nanocantilevers, nanotubes and nanowires for multiplexing detection, multifunctional 
injectable nanovectors for therapeutics and diagnostics. 
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INTRODUCTION
ᴪ 
 
Cancer is one of the leading causes of death 
worldwide especially in low income and middle 
income countries. As we all know, cancer is 
malignant neoplasm. There is uncontrolled division 
of cells which enter into normal adjacent tissues 
and destroy them. Often the abnormal cells also 
spread into other parts of the body via lymph or 
blood, popularly the situation known as metastasis. 
According to WHO (World Health Organization), 
cancer accounted for 7.4 million deaths in 2004 
which extended to 7.6 million which was about 
13% of all human cell deaths in 2007. Breast 
cancer, colorectal cancer, lung cancer, liver cancer 
and stomach cancer are some of the major types of 
cancer existing today. Deaths from cancer are 
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continuously rising worldwide with a projection of 
about 12 million deaths from cancer in 2030. 
Thereby, over the past few years, tremendous 
attention has been given to the cancer related 
research and developments. There has been an 
outstanding progress in the basic cancer biology. 
Many institutions, pharmaceutical and 
biotechnological industries have focused on cancer 
as their main target in their research and 
development departments. However, in spite of this 
progress in cancer research, comparable advances 
in cancer therapeutics have not taken place. The 
main reason for this failure was inability to deliver 
therapeutic moieties that selectively reach the 
desired targets which also resulted in unintended 
effects
1,2. In addition to this, inability of a 
therapeutic formulation to cross biological barriers 
has also been one of the main hindrances. To 
overcome above mentioned obstacles in cancer 
therapeutics, Nanotechnology seems to be a 
promising tool. 
Nanotechnology is one of the most rapidly growing 
and developing fields in the 21
st century. Mody et al / Cancer nanotechnology 
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Nanotechnology may be defined as the creation of 
materials, drugs and devices that are used to 
manipulate matter that are of size in the range of 1-
100nm
3. It has found applications in various fields 
including electronics, energy production, medicine, 
pharmaceutical industries to name a few. A 
nanometer is 1/50,000 times of the width of an 
average human hair. Moreover, the dimensions of a 
DNA strand are also in the range of nanometer. 
Similarly, a variety of biological processes takes 
place at nanometer scales. Thus, in order to 
communicate with these natural nanoclusters, a 
moiety with nanoscale dimensions would be 
appropriate. As a result, nanoparticles can offer 
some unique advantages in the field of 
biotechnology and medicine. Nanomaterials, due to 
their extremely small size, are readily taken up by 
the human body. In contrast to normal larger sized 
particles, they can cross the biological membranes 
and reach the cells, tissues and organs with ease. 
Mostly, biodegradable polymers are utilized in the 
preparation of the colloidal dispersions of 
nanoparticles. Drugs can be enclosed, entrapped or 
adsorbed onto the particle surface or dissolved 
within the matrix. Moreover, they have large 
surface area to volume ratio that aids in their 
diffusion through the membranes
4. Surface area to 
volume ratio is an important factor that governs the 
rate and the extent of absorption/diffusion of a 
chemical moiety across the biological membrane. It 
is the amount of surface area per unit volume of a 
substance and is inversely related with size. Thus, 
smaller the size as in case of nanoparticles, greater 
the surface area to volume ratio, greater the rate 
and extent of absorption/diffusion across the 
biological membranes.  Nanotechnology has found 
its applications in many fields related to medicine 
including novel drug delivery systems, 
biotechnology to name a few. Many different types 
of nanosystems have been utilized in diagnostics 
and therapeutics of various diseases. These may 
include silicon and silica based nanoparticles
5, gold 
nanoparticles
6, polymer based nanoparticles
7, 
dendrimers
8, liposomes
9, paramagnetic 
nanoparticles. In addition multifunctional 
nanoparticles have been also tested for their 
oncological applications. An example of their 
application is liposomal based drug delivery system 
of Doxorubin for the treatment of breast and 
ovarian cancer
9. The present article deals with the 
recent developments in cancer nanotechnologies 
and its potential application in cancer therapeutics. 
 
CURRENT CANCER 
NANOTECHNOLOGIES 
 
To subside the disadvantages of conventional 
cancer therapeutics, nanotechnology has been given 
considerable attention
5-9. In this section, the current 
nanotechnologies that can be utilized in oncological 
interventions will be discussed. These  mainly 
include arrays of nanocantilevers, nanotubes and 
nanowires for multiplexing detection, 
multifunctional injectable nanovectors for 
therapeutics and diagnostics. The effective 
utilization of nanosized, targeted MRI (Magnetic 
Resonance Imaging) contrast agents for 
oncological detection has been known for quite 
some time. 
 
Nanoparticles 
 
As compared to large sized particles, nanoparticles 
exhibit new or enhanced size dependant properties. 
They serve as the raw materials, ingredients or 
additives in various products
10. The control of cell 
and tissue distribution of anticancer agents is the 
biggest advantage of such nanoparticulate systems. 
Several types of nanoparticles have been developed 
and utilized in MRI (Magnetic Resonance Imaging) 
contrast. These include iron oxide based 
nanoparticles
11, gadolinium based nanoparticles
12 
to name a few. Local biology and pathology 
condition information can be obtained with the help 
of MRI. These are based on the nuclear magnetic 
resonance signals which are based on the hydrogen 
nuclei present in different pathological conditions 
in an organism
13. 
In addition to these, antibody conjugated gold 
nanoparticles have also been utilized for cancer 
diagnostics. Ivan et al have shown that with the aid 
of the unique optical properties of gold 
nanoparticles, such systems can have effective 
applications in cancer therapeutics. Such gold 
nanoparticles conjugated with monoclonal 
antibodies can be used in biosensor techniques in 
oral cancer diagnostics
14. Low density lipid 
nanoparticles have been developed to increase 
ultrasound imaging. Multimode imaging contrast 
nanoagents have also been developed combining 
biological targeting and magnetic resonance. 
 
Nanovectors 
 
Nanovectors are hollow or solid structured 
nanoparticles which can be filled with various 
anticancer drugs, targeting moieties and detection 
agents. The presence of targeting moieties 
attributes to their specificity; thereby reduction in 
toxic effects may be seen. These have been interest 
of use as nanotechnological devices in cancer. They 
are intravascular injectables considered for drug 
delivery and imaging in cancer. 
Nanovectors may be classified into different 
generation nanovectors-namely, first generation, 
second generation and third generation 
nanovectors
15. 
The first generation nanovectors are not targeted 
specifically against any biological molecule on the 
tumor cells
16. An example of this would be albumin Mody et al / Cancer nanotechnology 
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bound Paclitaxel. It has found its application in 
breast cancer chemotherapy. This chemotherapy 
enabled to overcome solubility problems related to 
Paclitaxel and improve the toxicity profile of 
conventional Paclitaxel therapy which was 
formulated with chemophor
17. 
The second generation of nanovectors was evolved 
for specific targeting. These nanovectors were 
developed to recognize and target specific 
biological molecules on the cancer cells (active 
targeting). Active targeting is one in which the 
therapeutic moiety or the drug is able to recognize 
and target specific moieties to the desired target on 
its own. This reduces the toxicity and would also 
improve therapeutic index. Coupling of high 
affinity ligands and specific antigens on the 
surfaces of nanoparticles
18 is an example of this 
generation of nanovectors. As compared to the first 
generation, they have improved biodistribution and 
reduced toxicity profile. The antigens on the cancer 
cells allow efficient uptake of targeted drugs 
through endocytosis (receptor mediated). The 
active drug delivery consists of several components 
like drug conjugated polymer and 
ligands/antibodies which are specific and bind to 
the specific tumor antigens/receptors. An example 
of this generation of nanovectors is liposome-
entrapped drugs with phospholipid-anchored folic 
acid-PEG conjugates put forth by Gabizon et al
19. 
However, further studies need to be carried out for 
its effective application in cancer therapeutics. 
The third generation of nanovectors is currently 
under development which is multi stage strategy 
based
20. The first stage particle can be 
biodegradable silicon microparticles which are 
having pores within them. They are designed to 
pass through the circulatory system and recognize 
the disease specific endothelium. The second stage 
particles are multitypes of nanoparticle which are 
loaded within the first stage particles. They are 
within the pores of the first stage particles and are 
set free towards the tumor mass. They are small 
enough (less than 20nm) to easily cross the inter-
endothelial junctions. They contain different 
payloads for therapy and imaging. They can 
effectively be utilized for cancer in future. 
Certain anticancer nanovectors have been 
developed which are targeted to tumors with the 
help of external magnetic field. Laurance et al have 
demonstrated their work on anticancer nanovectors 
based on superparamagnetic iron oxide 
nanoparticles
21. Nanovectors were designed with 
iron oxide nanoparticles constituting the core. 
Coating of the nanoparticles was carried out by 
incorporation of the nanoparticles in the polymer 
matrix or their surface was functionalized with 
polymers. They concluded that such nanovectors 
can be applied in cases when the solid tumor is 
close to the body surface. In addition, highly 
flexible nanovectors have also been developed with 
the aid of adhesion controlling and improving drug 
targeting and drug delivery
22.  
 
Liposomes 
 
Liposomes are the simplest forms of nanovectors 
which are made up of lipids enclosing water core. 
They have found applications in various cancer 
indications
23. With the aid of over expression of 
fenestrations in cancer neovasculature, they 
increase the drug concentration at the tumor sites 
(passive targeting). In passive targeting, the drug is 
targeted to the target site passively owing to the 
physiological conditions of the body. Various 
Doxorubin encapsulated liposomal formulations 
have been clinically utilized for the treatment of 
Kaposi’s sarcoma, breast cancer and refractory 
ovarian cancer
9. They were developed to improve 
therapeutic index of the conventional Doxorubin 
chemotherapy while maintaining its antitumor 
activity. Similarly, S. Kommareddy et al have 
shown effective utilization of gelatin based 
nanovectors in tumors. Here, PEG modified gelatin 
based nanovectors were used as safe and effective 
vehicle for the delivery of systemically 
administered genes for tumors. Ruthenium and 
complexes of several other heavy metals have 
shown potential applications in cancer therapeutics. 
Lipid based nanovectors containing such 
complexes have also been put forth as a potential 
route in cancer
24. 
 
Dendrimers 
 
Another type of nanoparticle, Dendrimers have also 
been of interest in cancer. They are self assembling 
synthetic polymers which were used in the MRI of 
lymphatic drainage in mouse model of breast 
cancer
25. Majoros et al have shown the synthesis, 
characterization and functionality of Poly 
(Amidoamine) (PAMAM) dendrimer based 
anticancer therapeutics. Such dendrimer based 
anticancer systems have found applications for 
targeted delivery in cancer (13). In addition to this, 
AK Patri et al have shown the synthesis and 
application of an antibody-dendrimer based 
conjugate system. Such systems have found 
applications in targeted delivery in prostate cancer 
therapeutics
26. Xiangyang et al have demonstrated 
that dendrimer-entrapped gold nanoparticles can be 
effectively utilized for cancer cell targeting and 
imaging purposes
27. 
 
Nanoshells 
 
Nanoshells are other nanoparticles which are being 
lined up in cancer therapeutics and diagnostics. 
They are composed of a gold shell surrounding a 
semiconductor. When they reach the cancer cells, 
they can be irradiated. These irradiations make Mody et al / Cancer nanotechnology 
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them hot which ultimately kill the cancer cells. 
This technique has been successfully  utilized in 
veneral tumours in mice
28. 
 
Nanobiosensors 
 
Varied types of novel devices are emerging with 
potential applications in cancer. Nanobiosensors 
have been developed for cancer diagnostics. 
Nanobiosensors are useful for early diagnosis of 
cancer. They can also effectively be utilized for the 
detection of cancer agents such as environmental 
pollutants, pathogens and carcinogenic gases. A 
device used for detection of an analyte through 
combination of a sensitive biological component, 
transducer along with a detector component is 
termed as a biosensor. These nanoscale sensors 
comprise of cancer specific antibody or ligands so 
that they can selectively capture cancer cells or 
target proteins. This yields mechanical, optical or 
electrical signals which can be detected by the 
detector. The use of nanobiosensors in cancer 
clinical testing have been increased due to high 
speed and reduced cost for diagnosis, automation 
and multi target analysis
29,30. For detection of 
DNA, Quantum dots based sensor has also been 
developed. 
 
Nanocantilevers 
 
Multimolecular mechanical sensing devices like 
nanocantilevers have also been emerged as one of 
the promising approaches. Nanocantilevers 
comprise of large number of beams. When specific 
biomolecules bind, deflection of beam takes place 
which is observed by laser light or other methods. 
The flexible beams are coated with molecules 
capable of binding to cancer biomarkers. 
 
Nanowires, Fullerenes and Nanotubes 
 
Nanowires, fullerenes and nanotubes are amongst 
others which are considered for cancer therapeutics 
and diagnostics. Fullerenes are nanostructured 
arrangement of carbon atoms in specific soccer like 
architecture. They may also form nanotubes which 
are cylindrical carbon atom assemblies. Nanotubes 
and fullerenes have found several specific sensing 
applications. For instance, Nanotubes have been 
developed as high specificity sensors of antibody 
signatures of autoimmune disease and SNPs (single 
nucleotide polymorphism). Nanowires are other 
class of nanotechnology that has been developed. 
They are sensing wires coated with antibodies like 
molecules to bind to proteins of interest. Silicon 
nanowires are one such real time detectors for 
simultaneous molecular binding effects. 
 
 
PRESENT CHALLENGES AND FUTURE 
PROSPECTS 
 
The application of nanotechnology in clinical use 
in cancer has found several drawbacks and 
challenges. Endothelial cell barriers on vessels, 
cellular uptake of therapeutic agent, clearance of 
drugs from circulation, heterogeneity among 
tumors are the present challenges. 
To conclude, the present cancer therapy needs 
advancement. However, cancer nanotechnology 
definitely can provide a breakthrough to eradicate 
cancer related death. Varied types of nanodevices 
have been developed which can effectively be 
applied in cancer therapeutics and diagnostics. Still 
extensive research needs to be carried out for 
effective utilization of cancer nanotechnology in 
clinic. There is need to identify favorable 
physiochemical properties and favorable 
nanodevices that will help to overcome multiple 
barriers. 
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